Literature DB >> 12204536

Mutations in a novel gene lead to kidney tumors, lung wall defects, and benign tumors of the hair follicle in patients with the Birt-Hogg-Dubé syndrome.

Michael L Nickerson1, Michelle B Warren, Jorge R Toro, Vera Matrosova, Gladys Glenn, Maria L Turner, Paul Duray, Maria Merino, Peter Choyke, Christian P Pavlovich, Nirmala Sharma, McClellan Walther, David Munroe, Rob Hill, Eamonn Maher, Cheryl Greenberg, Michael I Lerman, W Marston Linehan, Berton Zbar, Laura S Schmidt.   

Abstract

Birt-Hogg-Dubé (BHD) syndrome is a rare inherited genodermatosis characterized by hair follicle hamartomas, kidney tumors, and spontaneous pneumothorax. Recombination mapping in BHD families delineated the susceptibility locus to 700 kb on chromosome 17p11.2. Protein-truncating mutations were identified in a novel candidate gene in a panel of BHD families, with a 44% frequency of insertion/deletion mutations within a hypermutable C(8) tract. Tissue expression of the 3.8 kb transcript was widespread, including kidney, lung, and skin. The full-length BHD sequence predicted a novel protein, folliculin, that was highly conserved across species. Discovery of disease-causing mutations in BHD, a novel kidney cancer gene associated with renal oncocytoma or chromophobe renal cancer, will contribute to understanding the role of folliculin in pathways common to skin, lung, and kidney development.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12204536     DOI: 10.1016/s1535-6108(02)00104-6

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   31.743


  279 in total

1.  Genetic study in a case of birt-hogg-dubé syndrome.

Authors:  Geon Park; Hae Ryun Kim; Chan Ho Na; Kyu Chul Choi; Bong Seok Shin
Journal:  Ann Dermatol       Date:  2011-10-31       Impact factor: 1.444

Review 2.  Epigenetics of kidney cancer and bladder cancer.

Authors:  Amanda M Hoffman; Paul Cairns
Journal:  Epigenomics       Date:  2011-02       Impact factor: 4.778

Review 3.  Genetic interstitial lung disease.

Authors:  Megan Stuebner Devine; Christine Kim Garcia
Journal:  Clin Chest Med       Date:  2011-12-06       Impact factor: 2.878

Review 4.  Circulating biomarkers in advanced renal cell carcinoma: clinical applications.

Authors:  Maria Hernandez-Yanez; John V Heymach; Amado J Zurita
Journal:  Curr Oncol Rep       Date:  2012-06       Impact factor: 5.075

5.  Where Birt-Hogg-Dubé meets Cowden syndrome: mirrored genetic defects in two cases of syndromic oncocytic tumours.

Authors:  Laura Maria Pradella; Martin Lang; Ivana Kurelac; Elisa Mariani; Flora Guerra; Roberta Zuntini; Giovanni Tallini; Alan MacKay; Jorge S Reis-Filho; Marco Seri; Daniela Turchetti; Giuseppe Gasparre
Journal:  Eur J Hum Genet       Date:  2013-02-06       Impact factor: 4.246

6.  The role of the Birt-Hogg-Dubé protein in mTOR activation and renal tumorigenesis.

Authors:  T R Hartman; E Nicolas; A Klein-Szanto; T Al-Saleem; T P Cash; M C Simon; E P Henske
Journal:  Oncogene       Date:  2009-02-23       Impact factor: 9.867

7.  Early-onset renal cell carcinoma as a novel extraparaganglial component of SDHB-associated heritable paraganglioma.

Authors:  Sakari Vanharanta; Mary Buchta; Sarah R McWhinney; Sanna K Virta; Mariola Peçzkowska; Carl D Morrison; Rainer Lehtonen; Andrzej Januszewicz; Heikki Järvinen; Matti Juhola; Jukka-Pekka Mecklin; Eero Pukkala; Riitta Herva; Maija Kiuru; Nina N Nupponen; Lauri A Aaltonen; Hartmut P H Neumann; Charis Eng
Journal:  Am J Hum Genet       Date:  2003-12-18       Impact factor: 11.025

Review 8.  Precision medicine from the renal cancer genome.

Authors:  Yasser Riazalhosseini; Mark Lathrop
Journal:  Nat Rev Nephrol       Date:  2016-10-03       Impact factor: 28.314

9.  The TMEM127 human tumor suppressor is a component of the mTORC1 lysosomal nutrient-sensing complex.

Authors:  Yilun Deng; Yuejuan Qin; Subramanya Srikantan; Anqi Luo; Zi-Ming Cheng; Shahida K Flores; Kris S Vogel; Exing Wang; Patricia L M Dahia
Journal:  Hum Mol Genet       Date:  2018-05-15       Impact factor: 6.150

10.  The folliculin tumor suppressor is a GAP for the RagC/D GTPases that signal amino acid levels to mTORC1.

Authors:  Liron Bar-Peled; Lynne Chantranupong; Zhi-Yang Tsun; Roberto Zoncu; Tim Wang; Choah Kim; Eric Spooner; David M Sabatini
Journal:  Mol Cell       Date:  2013-10-03       Impact factor: 17.970

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.